RxDoctor Payments Data

Richard Okafor

Adult Reconstructive Orthopaedic Surgery · Round Rock, TXNPI 1184972366

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (51.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Arthrex at 39.2% of the total. Reporting peaked in 2019 at $7,913 and has fallen 82.9% since, to $1,357 in 2025.

$21,780in general payments, 2019–2025

Across 123 payments — averaging $177.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$9K
  • Pylant Medical$6K
  • Seapearl East, Inc$3K
  • Stryker$2K
  • Core Surgical Group$825
  • Smith+Nephew$374
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$4,91723%
  • Food & beverage$5,66726%
  • Education$11,19751%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,780 in reported general payments places this provider in the 65th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$104,869
Medicare patients
297
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib135$2,595
Meloxicam352$1,022
Doxycycline Monohydrate36$482
Gabapentin64$364
Methocarbamol38$325
Ondansetron OdtOndansetron39$290
Methylprednisolone32$253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$210
Oxycodone Hcl29$183
Tramadol Hcl18$43

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Round Rock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →